Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

337.65 +3.05 (+0.91%)
Official Closing Price Updated: 7:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,433,282
Open 335.80
Bid (Size) 336.50 (1)
Ask (Size) 338.99 (1)
Prev. Close 334.60
Today's Range 334.71 - 338.83
52wk Range 276.83 - 384.44
Shares Outstanding N/A
Dividend Yield 1.01%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mid-Cap Monday: ETF Fund Flows
The markets saw some green Monday after First Citizens Bank & Trust Co (NASDAQ: FCNCO) agreed to buy most of Silicon Valley Bank. The S&P 500 was up 0.29%, the Dow Jones Industrial Average gained 0.7%,... 
Via Benzinga
Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says
Earlier today, Viking Therapeutics Inc (NASDAQ: VKTX) announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735. 
Via Benzinga

Performance

YTD
-7.49%
-7.49%
1 Month
+6.64%
+6.64%
3 Month
-7.46%
-7.46%
6 Month
+9.80%
+9.80%
1 Year
+15.77%
+15.77%

More News

Read More
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?
Via The Motley Fool
Will Chart Analysts Notice Bad Omen on Eli Lilly's Chart
Via Benzinga
Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker
Via Investor's Business Daily
Why Novartis Shares Are Trading Higher Premarket Today
Via Benzinga
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
Via The Motley Fool
1 Stock Down 9% in 2023 to Buy and Hold Forever
Via The Motley Fool
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Via Investor's Business Daily
7 Hot Stocks To Turn $1,000 Into $10,000 By 2030
Via InvestorPlace
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is A Major Moment For Drug Development
Via Benzinga
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Via Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Via InvestorPlace
Peering Into Eli Lilly's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 5 Years
Via Benzinga
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
Beat the Dow Jones With This Unstoppable Dividend Stock
Via The Motley Fool
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
Via Benzinga
Three Is Company - Sanofi Follows Lilly, Novo Nordisk, Slashes Insulin Product Price By 78%
Via Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
Via Benzinga
Eli Lilly Stock Shows Improved Relative Price Performance; Still Shy Of Benchmark
Via Investor's Business Daily
Novo Nordisk Follows Eli Lilly In Slashing Insulin Prices By 75%
Via Benzinga
Eli Lilly, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling
Via Benzinga
Why Eli Lilly Stock Cruised to a 3% Gain on Monday
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.